http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021008434-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77e3ab2dbcbc0bb304d2a9e9bbbb095a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12b33ff9c707805d05465005aad604bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a96ccbd92b15ff6e24e011891adc8c60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c80aea3873cff7275580407996d2199a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_345ce03257a4dffaccf7308cdc157565 |
| publicationDate | 2021-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021008434-A |
| titleOfInvention | Composition for reducing blood glucose concentration, reducing blood hemoglobin A1c amount, or increasing blood HDL-cholesterol level |
| abstract | PROBLEM TO BE SOLVED: To provide a composition for improving lipid metabolism or sugar metabolism, which comprises a component derived from turmeric as an active ingredient. The present invention is a composition for reducing blood glucose concentration, reducing blood hemoglobin A1c amount, or increasing blood HDL-cholesterol amount, which contains at least one of turmeronol A, turmeronol B and bisaclone as an active ingredient. The present invention relates to a substance, a composition for treating or preventing metabolic syndrome, or a composition for improving lipid metabolism or glucose metabolism. The composition of the present invention can contain 20 μg or more of turmeronol A and turmeronol B in total per daily intake, and can contain 17 μg or more of turmeronol A per daily intake. It is possible to contain 5 μg or more of Termeronol B per ingestion of, and 80 μg or more of Bisacurone per daily intake. [Selection diagram] Fig. 1 |
| priorityDate | 2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.